Acute and Sub-Chronic (28-Day) Oral Toxicity Studies of Hydroalcohol Leaf Extract of Ageratum Conyzoides L (Asteraceae)
Acute and Sub-Chronic (28-Day) Oral Toxicity Studies of Hydroalcohol Leaf Extract of Ageratum Conyzoides L (Asteraceae)
Acute and Sub-Chronic (28-Day) Oral Toxicity Studies of Hydroalcohol Leaf Extract of Ageratum Conyzoides L (Asteraceae)
) were
used for spectrophotometric determination of
the following biochemical parameters: alanine
aminotransferase (ALT), aspartate amino-
transferase (AST), creatinine, alkaline
phosphatase, glucose, total proteins and
urea.
Necroscopy of all animals was carried and
the organ weights (heart, liver, kidney and
spleen) were recorded.
Statistical analysis
The results are expressed as mean
standard error of the mean (SEM). Statistical
analysis was performed by one-way analysis
of variance (ANOVA) with Tukey test to
evaluate significant differences between
groups. Values of p < 0.05 were considered
significant. All statistical analyses were
carried out using the Instat statistical package
(Graph Pad Software, Inc., USA).
RESULTS
Acute toxicity
The limit dose of 5 g/kg did not cause
mortality or any sign of acute toxicity in the
three rats dosed for a short period (48 h) and
long period (14 days).
Sub-chronic toxicity
No behavioural changes and death were
observed at the end of the treatment.
Similarly, no significant differences in body
weight were observed between control and
treated groups during this period (see Table
1).
Table 1: Mean body weight of rats after 28 days
treatment with hydroalcohol leaf extract of A.
conyzoides
Mean body weight (g, SEM)
Control Extract
Week
500 mg/kg
1000
mg/kg
0 132 4.8 135 5.2 129 4.5
1 139 5.4 139 4.1 133 4.2
2 142 5.1 144 3.9 137 4.7
3 148 4.8 151 4.4 143 5.4
4 152 5.5 156 5.2 147 6.4
Fig 2 shows that the weight of liver in the
group treated with 1000 mg/kg significantly
higher (p < 0.05) than that of the control
group. For other organs and at both doses
tested, there were no changes in organ
weight
Table 2: Mean organ weight of rats after 28 days
treatment with hydroalcohol leaf extract of A.
conyzoides
Mean weight (g, SEM)
Control Extract dose
Organ
500 mg/kg 1000 mg/kg
Heart
0.340.02(8) 0.330.01(8) 0.340.01(7)
Liver
2.500.12(8) 2.700.11(8) 3.000.15(7)*
Spleen 0.170.02(8) 0.180.018(8) 0.230.03(7)
Kidney
0.550.08(8) 0.540.020(8) 0.600.03(7)
Testis 1.300.08(4) 1.000.26(4) 1.000.23(4)
No. of rats/group indicated in parenthesis; * p <0.05,
control group vs extract
Diallo et al
Trop J Pharm Res, October 2010; 9 (5): 466
Tables 3 and 4 show the haematological and
biochemical parameters for the rats after sub-
chronic toxicity dosing
Table 3: Haematological parameters for rats after 28
days treatment with hydroalcoholic extract of A.
conyzoides leaves.
Control
Extract dose
Parameter
500
mg/kg
1000
mg/kg
WBC (10
3
/l) 9.70.9 (8) 9.90.9 (7) 8.71.3 (7)
RBC (10
6
/l) 7.40.1 (8) 6.90.4 (7) 7.00.2 (7)
Haemoglobin
(g/dL)
14.00.4 (8) 14.00.4 (7) 13.00.4 (7)
Haematocrit
(%)
42.00.9 (8) 40.02.2 (7) 41.01.4 (7)
MCV (fl) 57.00.6 (8) 57.00.6 (7) 56.00.9 (7)
MCH (pg) 18.00.4 (8) 20.01.5 (7) 19.00.4 (7)
MCHC (%) 32.00.6 (8) 35.02.4 (7) 33.00.8 (7)
Platelet
(10
3
/L)
92645 (8)
80164 (7)
96643 (7)
No. of rats/group indicated in parenthesis
Table 4: Biochemical parameters for rats
after 28 days treatment with hydroalcohol
extract of A. conyzoides leaves.
Extract dose
Parameter
Control
500
mg/kg
1000
mg/kg
ASAT (U/L) 24125 (8) 20625 (8) 22916 (7)
ALAT (U/L) 6911 (8) 665 (8) 607 (7)
Total proteins
(g/dL)
6.02.2 (8) 6.21.8 (8) 6.51.4 (7)
Creatinine
(mg/dL)
8.50.7 (8) 7.90.4 (8) 7.40.9 (7)
Urea (mg/dL) 454 (8) 292 (8)* 354 (7)
Alkaline
phosphatase
(U/L)
27352 (8) 21545 (8) 22556 (7)
No. of rats/group indicated in parenthesis;
*Statistically significant (p <0.05, control group vs
extract)
Only urea showed any significant change (p
<0.05) being lower in the group treated with
500 mg/kg of the extract than in the control.
Other biochemical and haematological
parameters were similar for the two groups.
DISCUSSION
The results of the acute toxicity study indicate
that the LD
50
of the extract of A. conyzoides
extract is more than 5000 mg/kg. The limit
test is primarily used in situations where the
investigator has information indicating that
the test material is likely to be non-toxic or of
low toxicity [12]. This finding, therefore,
suggests that the extract at the limit dose
tested is essentially non-toxic and safe in oral
formulation. This result is in line with previous
data from Moura et al [11] who reported that
A. conyzoides LD
50
in mice is more than
10,000 mg/kg.
After 28 days of treatment, there were no
treatment-related changes in haematological
parameters between control and treated
groups, indicating that the extract was not
toxic to circulating red cells, nor interfered
with their production and that of platelets. The
haematopoietic system is one of the most
sensitive targets of toxic compounds and is
an important index of physiological and
pathological status in man and animals [14].
In addition, most of the biochemical
parameters were not also altered by the
extract. The lack of significant alterations in
the levels of ALT, AST, alkaline phosphatase,
glucose and creatinine, which are good
indicators of liver and kidney functions,
suggests that sub-chronic administration of
extract neither altered hepatocytes and
kidneys of rats nor the normal metabolism of
the animals. The extract produced significant
decrease in urea levels at the lower dose
(500 mg/kg); the reason is not exactly known
but one possibility could be that the different
active principles present in the extract are
acting differently at the doses tested and
moreover, some drugs are known to
decrease blood urea levels [15].
The change in the relative weight of the liver
and the presence of several alkaloids,
including 1.2-desifropirrolizidinic and licopsa-
Diallo et al
Trop J Pharm Res, October 2010; 9 (5): 467
mine, which can have hepatotoxic activity
[13]
indicate that the extract might have toxic
potential on liver with increasing dose.
However, it could be argued that these
changes may not be toxicologically
significant, as they were not corroborated by
the biochemical findings (ALT, AST, alkaline
phosphatase and glucose). Further
histological study and more specific assays of
toxicity could furnish more information
regarding the hepatotoxicity of the extract.
CONCLUSION
Our results have demonstrated that the
hydroalcohol leaf extract of A. conyzoides is
relatively safe when administered orally in
rats.
REFERENCES
1. Abena AA, Ouamba JM, Keita A. Anti-inflammatory,
analgesic and antipyretic activities of essential
oil of Ageratum conyzoides. Phytother Res
1996; 10: S164-S165.
2. Githen, TS. Fundamentals of Experimental
Pharmacology. Scientific Book
Agency.Calcutta; 1948. 153 p.
3. Adjanohoun EJ, Adjakidj V, Ahyi MRA, Ake-Assi L,
Akoegninou A., DAlmeida J., Apovo F.,
Boukef K., Chadare M., Cusset G. et al.
Contribution aux tudes ethnobotaniques et
floristiques en Rpublique populaire du Bnin.
Agence de coopration culturelle et technique
1
st
d. Paris ; 1989. 698-699.
4. Okunade AL. Review: Ageratum conyzoides L.
(Asteraceae). Fitoterapia 2002; 2: 1-16
5. Igoli JO, Ogaji OG, Tor-Anyiin TA, Igoli NP.
Traditional medicine practice amongst the
Igede people of Nigeria. Part II. Afr. J. Trad.
Comp. Alt. Med. 2005; 2: 134-152
6. Vyas AS, Mulchandani NB. Polyoxygenated
flavones from Ageratum conyzoides.
Phytochemistry 1986; 25: 2625-2627
7. Horie T, Tominaga H, Kawamura Y. Revised
structure of natural flavone from Ageratum
conyzoides. Phytochemistry 1993 ; 32: 1076-
1077
8. Moore DJ, Batts KP, Zalkow LL, Fortune GTJr,
Powis G. Model systems for detecting the
hepatic toxicity of pyrrolizidine alkalodes and
pyrrolizidine alkaloid N-oxides. Toxicol. Appl.
Pharmacol. 1989; 101: 271-284
9. Quijano L, Calderson JS, Gomez GF, Soria IE, Rios
T. Highly oxygenated flavonoides from
Ageratum conyzoides. Phytochemistry 1980;
19: 2439-2442.
10. Xuan TD, Shinkichi T, Hong NH, Khanh TD, Min
CT. Assessment of phytotoxin action of
Ageratum conyzoides L. on weeds. Crop
Protection 2004; 23: 915-922.
11. Moura ACA, Silva ELF, Fraga MCA, Wanderley AG,
Afiatpour P, Maia MBS. Anti-inflammatory and
chronic toxicity study of leaves of Ageratum
conyzoides L. in rats, Phytomedicine 2005; 12:
138-142.
12. OECD. Guidelines for the Testing of Chemicals /
Section 4: Health Effects Test No. 423: Acute
Oral toxicity - Acute Toxic Class Method.
Organization for Economic Cooperation and
Development, Paris, France; 2002.
13. OECD. Repeated dose oral toxicity test method. In:
OECD Guidelines for testing of chemicals, N
407. Organization for Economic Cooperation
and Development, Paris, France; 2008.
14. Adeneye AA, Ajagbonna OP, Adeleke TI, Bello SO.
Preliminary toxicity and phytochemical studies
of the stem bark aqueous extract of Musanga
cecropioides in rats. J Ethnopharmacol 2006;
105: 374-379.
15. Kkdil G, Tamar L, Ercan B, Celik M, Atik U. Effects
of Nigella orientalis and N. segetalis fixed oils
on blood biochemistry in rats. Phytother Res
2006; 20: 71-75.